Introduction of ibnfluenza vaccines
Journal
Journal of Internal Medicine of Taiwan
Journal Volume
31
Journal Issue
1
Pages
7-10
Date Issued
2020
Author(s)
Abstract
Influenza infection is a threat to human health and cause a huge healthcare burden every year. Annual influenza vaccination is the primary strategy for the prevention and control of influenza, but the influenza vaccine effectiveness (VE) varies from year to year. The potential etiologies include not only the match between the vaccine and circulating viruses but also manufacturing technologies in vaccine production. Besides, the host immunity is also an important factor to determine VE. Generally, influenza VE in older adults is less than that in young/ middle-aged adults or children. But influenza vaccination can reduce the severity of illness in all age groups of people who get vaccinated but still get sick. Meanwhile, influenza vaccination can prevent people with chronic health conditions from i complicated disease courses when they get sick. Based on current evidence, the United States Advisory Committee on Immunization Practices during the 2019-2020 season also recommend cancer patients to receive annual inactivated influenza vaccination, even those receiving immune checkpoint inhibitors. Additionally, the inactivated influenza vaccines are generally well tolerated with minor adverse events. Collectively, annual influenza vaccination is necessary for all individuals six months of age and older. ? 2020 Society of Internal Medicine of Taiwan. All rights reserved.
Other Subjects
checkpoint kinase inhibitor; influenza vaccine; Article; cancer patient; chronic disease; disease course; disease severity; drug tolerability; groups by age; human; infection control; infection prevention; influenza; influenza vaccination; unspecified side effect; vaccine production
Publisher
Society of Internal Medicine of Taiwan
Type
journal article